Year-Long epilepsy drug trial seeks to control seizures
NCT ID NCT07141329
Summary
This study follows up on previous research to test SPN-817's long-term safety and effectiveness in controlling seizures over one year. It involves 100 adults with focal onset seizures who previously participated in an SPN-817 study. Participants will receive the medication for a year while researchers monitor side effects and measure how well it reduces seizure frequency.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL ONSET SEIZURES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medsol Clinical Research Center
RECRUITINGPort Charlotte, Florida, 33952, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.